Pay in 4 interest-free payments of $5.26 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Current Lilly programs can put an eligible 28-day Zepbound supply as low as $25 with qualifying commercial coverage or start a KwikPen self-pay purchase at $299, but the exact amount depends on the device, dose, insurance result, and program eligibility
That rate is meaningfully higher than typical single-agonist GLP-1 tolerability profiles
Retatrutide may appeal to those who want a more aggressive approach, since it addresses both appetite and energy expenditure
PMID: 27450738 | doi:10.1016/bs.vh.2016.04.005 Dalmasso G et al
R., Doody, R
US$ 22.09
US$ 21.04
US$ 27.51
US$ 28.79
US$ 25.79
